These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

557 related articles for article (PubMed ID: 25855702)

  • 1. Direct-acting oral anticoagulants as emerging treatment options for heparin-induced thrombocytopenia.
    Miyares MA; Davis KA
    Ann Pharmacother; 2015 Jun; 49(6):735-9. PubMed ID: 25855702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Heparin-induced thrombocytopenia. New therapeutical options].
    Seculini Patiño CE; Tabares AH
    Medicina (B Aires); 2016; 76(4):230-4. PubMed ID: 27576282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel oral anticoagulants for heparin-induced thrombocytopenia.
    Skelley JW; Kyle JA; Roberts RA
    J Thromb Thrombolysis; 2016 Aug; 42(2):172-8. PubMed ID: 27102287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential Role of Direct Oral Anticoagulants in the Management of Heparin-induced Thrombocytopenia.
    Barlow A; Barlow B; Reinaker T; Harris J
    Pharmacotherapy; 2019 Aug; 39(8):837-853. PubMed ID: 31233222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct acting oral anticoagulants for the treatment of suspected heparin-induced thrombocytopenia.
    Davis KA; Davis DO
    Eur J Haematol; 2017 Oct; 99(4):332-335. PubMed ID: 28672052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging Role of Direct Oral Anticoagulants in the Management of Heparin-Induced Thrombocytopenia.
    Tran PN; Tran MH
    Clin Appl Thromb Hemost; 2018 Mar; 24(2):201-209. PubMed ID: 28301915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy and safety of direct oral anticoagulants in the treatment of the acute phase of heparin-induced thrombocytopenia: A systematic review.
    Sadowski C; Reinert JP
    Am J Health Syst Pharm; 2024 Sep; 81(19):e584-e593. PubMed ID: 38651828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct oral anticoagulants for treatment of HIT: update of Hamilton experience and literature review.
    Warkentin TE; Pai M; Linkins LA
    Blood; 2017 Aug; 130(9):1104-1113. PubMed ID: 28646118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New Oral Anticoagulants for the Management of Heparin Induced Thrombocytopenia: A Focused Literature Review.
    Dhakal P; Pathak R; Giri S; Murthy GS; Bhatt VR
    Cardiovasc Hematol Agents Med Chem; 2015; 13(2):87-91. PubMed ID: 26695419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparin-induced thrombocytopenia: in vitro studies on the interaction of dabigatran, rivaroxaban, and low-sulfated heparin, with platelet factor 4 and anti-PF4/heparin antibodies.
    Krauel K; Hackbarth C; Fürll B; Greinacher A
    Blood; 2012 Feb; 119(5):1248-55. PubMed ID: 22049520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin-induced thrombocytopenia: pathophysiology, diagnosis and treatment.
    Hvas AM; Favaloro EJ; Hellfritzsch M
    Expert Rev Hematol; 2021 Apr; 14(4):335-346. PubMed ID: 33736552
    [No Abstract]   [Full Text] [Related]  

  • 12. How we manage patients with heparin induced thrombocytopenia.
    Scully M; Gates C; Neave L
    Br J Haematol; 2016 Jul; 174(1):9-15. PubMed ID: 27097741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rivaroxaban and apixaban for the treatment of suspected or confirmed heparin-induced thrombocytopenia.
    Cirbus K; Simone P; Austin Szwak J
    J Clin Pharm Ther; 2022 Jan; 47(1):112-118. PubMed ID: 34704283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The approach to heparin-induced thrombocytopenia.
    Linkins LA; Warkentin TE
    Semin Respir Crit Care Med; 2008 Feb; 29(1):66-74. PubMed ID: 18302088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging therapy options in heparin-induced thrombocytopenia.
    Chaudhary RK; Khanal N; Giri S; Pathak R; Bhatt VR
    Cardiovasc Hematol Agents Med Chem; 2014; 12(1):50-8. PubMed ID: 25374012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Argatroban for prevention and treatment of thromboembolism in heparin-induced thrombocytopenia.
    Kondo LM; Wittkowsky AK; Wiggins BS
    Ann Pharmacother; 2001 Apr; 35(4):440-51. PubMed ID: 11302409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparin-induced thrombocytopenia in intensive care patients.
    Selleng K; Warkentin TE; Greinacher A
    Crit Care Med; 2007 Apr; 35(4):1165-76. PubMed ID: 17334253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Multicenter Retrospective Evaluation of Direct Oral Anticoagulants for the Treatment of Heparin-Induced Thrombocytopenia.
    Davis K; Sebaaly J; Wooten L; Khouli C; Mihm A; Nisly SA
    Am J Cardiovasc Drugs; 2022 Jul; 22(4):417-424. PubMed ID: 35040095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rivaroxaban as an Alternative Agent for Heparin-Induced Thrombocytopenia.
    Farasatinasab M; Zarei B; Moghtadaei M; Nasiripour S; Ansarinejad N; Zarei M
    J Clin Pharmacol; 2020 Oct; 60(10):1362-1366. PubMed ID: 32519800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rivaroxaban--an oral, direct Factor Xa inhibitor--has potential for the management of patients with heparin-induced thrombocytopenia.
    Walenga JM; Prechel M; Jeske WP; Hoppensteadt D; Maddineni J; Iqbal O; Messmore HL; Bakhos M
    Br J Haematol; 2008 Oct; 143(1):92-9. PubMed ID: 18671707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.